Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-1-17
|
pubmed:abstractText |
Twenty-three residential patients on chronic antiepileptic drugs (AEDs) were entered into an open study of 4 weeks duration. Baseline variables and seizure frequency were determined in the first week. All patients received a single dose of lamotrigine in the second week to determine single-dose pharmacokinetic parameters. Twenty patients then received daily or twice daily lamotrigine for a week. Post-treatment seizure frequency was observed for a further week. Patients taking liver enzyme inducing antiepileptic drugs showed a mean lamotrigine plasma elimination half-life (T1/2) of 14 h (+/- 7) (T1/2 of normal volunteers = 24 h) and those taking sodium valproate and an inducing AED showed a mean lamotrigine T1/2 of 30 h (+/- 10). The plasma concentrations of co-administered sodium valproate, phenytoin, carbamazepine, phenobarbitone and primidone were not altered by 1 week lamotrigine dosing. There was a significant reduction in complex partial seizures in the treatment week compared with baseline. Some patients showed a marked increase in seizure frequency on stopping lamotrigine. There was an increase in reports of drowsiness during lamotrigine administration, but there were no clinically significant changes in any safety measure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0920-1211
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
194-201
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3504397-Adolescent,
pubmed-meshheading:3504397-Adult,
pubmed-meshheading:3504397-Anticonvulsants,
pubmed-meshheading:3504397-Dose-Response Relationship, Drug,
pubmed-meshheading:3504397-Drug Interactions,
pubmed-meshheading:3504397-Drug Tolerance,
pubmed-meshheading:3504397-Epilepsy,
pubmed-meshheading:3504397-Female,
pubmed-meshheading:3504397-Humans,
pubmed-meshheading:3504397-Male,
pubmed-meshheading:3504397-Middle Aged,
pubmed-meshheading:3504397-Triazines
|
pubmed:year |
1987
|
pubmed:articleTitle |
Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy.
|
pubmed:affiliation |
Chalfont Centre for Epilepsy, Chalfont St. Peter, U.K.
|
pubmed:publicationType |
Journal Article
|